Inhibition of the Na,K-ATPase by the antiarrhythmic drug, Bretylium.
Inhibition of the Na,K-ATPase by the antiarrhythmic drug, Bretylium.
复制标题
抗心律失常药物 Bretylium 抑制 Na,K-ATP 酶。
DOI:
10.1111/j.1749-6632.2003.tb07265.x
复制
发表时间:
2003
影响因子:
5.2
通讯作者:
Milanick,MarkA
中科院分区:
文献类型:
--
作者:
Gatto,Craig;Barkulis,CTheodore;Schneider,WilliamR;Holden,JeremyP;Arnett,KristaL;Milanick,MarkA
Bretylium (BrT) is a quaternary amine used extensively as a potassium channel blocker. 1 Here, we report that BrT also inhibits the Na, K-ATpase; the BrT IC50 value (at 20 mM K+) was approximately 5 mM. Interestingly, enzyme activity followed a biphasic pattern in response to BrT; initially, BrT stimulated Na, K-ATpase ([BrT]≤ 1 mM), followed by an inhibitory effect. We limit our discussion to BrT inhibition of the Na, K-ATpase.Increasing concentrations of K (or Rb) were able to overcome the inhibitory effect of BrT, and the maximal velocity for ATpase activity was unchanged. In contrast, increasing Na concentration was unable to compete with BrT and Vmax was significantly reduced. These observations are in line with reports of BrT inhibition of guinea pig cardiac Na, K-ATpase. 2 We observed that 50 mM BrT (ie, 10 times the IC50 for ATpase) was unable to prevent the formation of Eap from Na and MgATp. 3 These observations, together with K competition, suggest that BrT, a cation, inhibits the Na pump by binding to E2-p. Based on this and previous work, it appears that BrT inhibits the Na pump by preventing extracelluar K binding. 3
DOI:
10.1073/pnas.090492697
发表时间:
2000-05-23
影响因子:
11.1
作者:
Garfinkel, A;Kim, YH;Chen, PS
通讯作者:
Chen, PS
DOI:
10.1016/0306-3623(91)90233-v
发表时间:
1991
期刊:
General pharmacology
影响因子:
--
作者:
N. Dzimiri;A. Almotrefi
通讯作者:
A. Almotrefi